Lilly said to be readying $2bn-plus bid for Kelonia
Eli Lilly is said to be lining up another acquisition, with in vivo cell therapy developer Kelonia the latest target to be mentioned in dispatches.
The future of cardiometabolic trials: From obesity to outcom...
Gain practical insight into how leading experts are designing the next generation of cardiometabolic trials in an upcoming webinar from hVIVO
12 questions with: Daniel Kohlstaedt
Daniel Kohlstaedt, managing director of PurpleLeaf Strategy, with more than 18 years of experience in pharma, talks about his journey through the industry.
A data-driven guide to small molecule drug discovery and dev...
A new white paper from Excelra takes a closer look at how discovery teams actually experience the small molecule development journey.
Expert Directed Applied Intelligence: Redefining AI in Life ...
In a new white paper from Lumanity, explore why the most powerful AI will always be human-directed.
Emerging Trends in Personalised Medicine at PHARMAP 2026
The Pharmaceutical Manufacturing & Packaging Congress is an exclusive annual event that fosters networking and knowledge-sharing among professionals
5th mRNA-Based Therapeutics Summit Europe
The Summit is the leading European industry-focused forum dedicated to accelerating the development of messenger RNA (mRNA) medicines
